UPDATE -- uniQure to Participate in Multiple Upcoming Industry Conferences in June
02. Juni 2021 10:31 ET
|
uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, June 02, 2021 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical...
uniQure to Participate in Multiple Upcoming Industry Conferences in June
02. Juni 2021 07:34 ET
|
uniQure Inc.
LEXINGTON, Mass. and AMSTERDAM, June 02, 2021 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical...
uniQure Highlights Pipeline Expansion and Advancements in Technology at Research & Development Day
19. November 2018 12:15 ET
|
uniQure Inc.
~ Unveils New AAV Gene Therapy Approaches to Hemophilia A, Fabry Disease and Spinocerebellar Ataxia Type 3 ~ ~ Introduces miQURE™ Gene Silencing Platform with Applications Across Multiple Indications...
uniQure to Host Research & Development Day on Monday, November 19 in New York City
05. November 2018 07:00 ET
|
uniQure Inc.
~ Event to be Webcast Live on Corporate Website ~ LEXINGTON, Mass and AMSTERDAM, the Netherlands, Nov. 05, 2018 (GLOBE NEWSWIRE) -- uniQure N.V. (NASDAQ: QURE), a leading gene therapy company...